Bank of America
DMAC icon

Bank of America’s DiaMedica Therapeutics DMAC Stock Holding History

Bank of America’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$290K Buy
42,768
+16,446
+62% +$130K ﹤0.01% 5171
2025
Q4 		$210K Buy
26,322
+14,073
+115% +$105K ﹤0.01% 5324
2025
Q3 		$84.2K Buy
12,249
+3,752
+44% +$20.4K ﹤0.01% 6667
2025
Q2 		$33.1K Buy
8,497
+8,274
+3,710% +$32.3K ﹤0.01% 6928
2025
Q1 		$845 Buy
223
+14
+7% +$80 ﹤0.01% 7449
2024
Q4 		$1.14K Sell
209
-4
-2% -$19 ﹤0.01% 7268
2024
Q3 		$892 Buy
213
+30
+16% +$111 ﹤0.01% 7265
2024
Q2 		$540 Buy
+183
New +$502 ﹤0.01% 7342
2024
Q1 		– Sell
-15
Closed -$43 – 7829
2023
Q4 		$43 Buy
+15
New +$37 ﹤0.01% 7520
2023
Q1 		– Sell
-40
Closed -$64 – 7895
2022
Q4 		$64 Buy
+40
New +$54 ﹤0.01% 7757
2022
Q3 		– Sell
-3
Closed – – 7913
2022
Q2 		$0 Hold
3
– – ﹤0.01% 8087
2022
Q1 		$0 Hold
3
– – ﹤0.01% 8354
2021
Q4 		$0 Buy
+3
New +$12 ﹤0.01% 8300
2021
Q3 		– Sell
-145
Closed -$1K – 8160
2021
Q2 		$1K Buy
145
+77
+113% +$631 ﹤0.01% 7599
2021
Q1 		$1K Buy
+68
New +$635 ﹤0.01% 7303
2020
Q3 		– Sell
-73
Closed -$1K – 6945
2020
Q2 		$1K Buy
+73
New +$326 ﹤0.01% 6724
2019
Q4 		– Sell
-211
Closed – – 7140
2019
Q3 		$0 Buy
+211
New +$682 ﹤0.01% 7296
2019
Q1 		– Sell
-5,900
Closed -$17K – 7165
2018
Q4 		$17K Buy
+5,900
New +$18.5K ﹤0.01% 6515

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of America's DMAC Position: Q1 2026 in Review

Bank of America increased its DiaMedica Therapeutics (DMAC) stake by 62% in Q1 2026, buying an estimated $130K and bringing the position to 42,768 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #5171.

Bank of America first reported a position in DMAC in Q4 2018 and has held it in 18 quarters since. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • Bank of America held 42,768 shares of DiaMedica Therapeutics worth $290K as of Q1 2026.
  • Bank of America bought 16,446 DiaMedica Therapeutics shares in Q1 2026, an estimated $130K.
  • DiaMedica Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5171 holding.
  • Bank of America first reported a position in DiaMedica Therapeutics in Q4 2018 and has held it in 18 quarters since.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.